Apr 02, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. VVUS Stock Price | VIVUS Inc. Stock Quote (U ... - MarketWatch VVUS | Complete VIVUS Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. VVUS Message Board - valueforum.com VVUS is rated 1.00 on average by 1 ValueForum.com member(s) [ on a scale of (Strong Buy) 1.00 - 5.00 (Strong Sell) ] in the stock ratings area. The latest rating update was made on Sep. 14 2015, 5:01 PM ET. As a private members-only community, the VVUS message board discussions and further stock rating information, including commentary by the 1 member(s) entering the ratings, is available to VIVUS, Inc. - TheStreet Vivus (VVUS) Stock Falls Following Earnings Release, Restructuring Plan. By Tony Owusu. Jul 31, 2015 3:25 PM EDT. INVESTING. 4 Stocks Under $10 Making Big Moves Higher. By Roberto Pedone.
VIVUS, Inc. Common Stock (VVUS) News Headlines | Nasdaq
Find the latest VIVUS, Inc. (VVUS) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Sign in to post a message. Top reactions. R. RENDILL. Long time board members will easily recall that I have said countless times that I believe that Vvus has more leaks in it than a VVUS - Vivus Stock Barchart Opinion - Barchart.com Barchart Opinion & Trading Performance. Barchart Opinions add market-timing information by calculating and interpreting signal strength and direction. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. VIVUS Share Chart - VVUS | ADVFN VIVUS (VVUS) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more. VVUS Insider Trading - VIVUS, Inc.
Find the latest VIVUS, Inc. (VVUS) stock quote, history, news and other vital information to help you with your stock trading and investing.
5 Feb 2020 VVUS stock is gaining after VIVUS announced that the FDA had granted approval of the company's new formulation of Pancreaze. Learn more. Vivus Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock analysis for VIVUS Inc (VVUS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock Message Boards, Discussion Forums, NYSE, NASDAQ, AMEX, TSX, OTCBB, Pink Sheets, Penny Stocks, Global Markets, FOREX, Stock Quotes, Stock Charts. 04/02/2020 2:55:45 PM. VVUS VIVUS, Inc. Total Posts:(37). 04/ 02/2020 VVUS VIVUS, Inc. daily Stock Chart Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors GlobeNewswire Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit GlobeNewswire. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Vivus Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate Stocks Rankings for VVUS. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and
VVUS Message Board - valueforum.com
VIVUS, Inc. - TheStreet Vivus (VVUS) Stock Falls Following Earnings Release, Restructuring Plan. By Tony Owusu. Jul 31, 2015 3:25 PM EDT. INVESTING. 4 Stocks Under $10 Making Big Moves Higher. By Roberto Pedone. VVUS Stock | Message Board | VIVUS, Inc. - Investors Hangout VVUS Stock Message Board for Investors. VIVUS, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 35 VVUS: Vivus Inc - Stock Price, Quote and News - CNBC Get Vivus Inc (VVUS:NASDAQ) real-time stock quotes, news and financial information from CNBC. Sign up for free newsletters and get more CNBC delivered to your inbox. Sign Up Now. VVUS Stock Price & Charts | VIVUS
Mar 26, 2020 · VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10- K for the year ended December 31, 2006 and periodic reports filed with the Securities and Exchange Commission .
VIVUS Stock Rating and Data | VVUS - GuruFocus.com VIVUS stock rating and analysis - VVUS : a summary of key financial strength and profitability metrics. Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Latest Guru Picks Real Time Picks List of Gurus Guru Portfolio Score Board Top 10 Holdings View Sector Picks VVUS VIVUS, Inc. Stock Message Board VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA. VIVUS: Advancing Innovative Clinical Therapies Advancing Innovative Clinical Therapies. With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. VVUS | VIVUS INC | Research - Stock Message Boards